Vivos Therapeutics, Inc.
VVOS
$0.57
-$0.04-6.80%
NASDAQ
Rating
Reward
Risk
Rating Factors
Growth Index
Efficiency Index
Solvency Index
Total Return Index
Volatility Index
Dividend Yield Index
Headlines
6/11/2026
-
TipRanks: TheFly
6/11/2026
-
Globe Newswire
6/10/2026
-
TipRanks: TheFly
6/10/2026
-
Globe Newswire
6/8/2026
-
Globe Newswire
6/5/2026
-
Globe Newswire
5/30/2026
-
The Cerbat Gem
5/23/2026
-
TipRanks Financial Blog
5/22/2026
-
TipRanks Financial Blog
5/21/2026
-
TipRanks Financial Blog
5/21/2026
-
SeekingAlpha
5/20/2026
-
The Cerbat Gem
5/20/2026
-
SeekingAlpha.com: All News
5/20/2026
-
Globe Newswire
5/15/2026
-
TipRanks Financial Blog
5/15/2026
-
Zacks Investment Research
5/15/2026
-
Zacks Investment Research
5/9/2026
-
Invezz News
4/17/2026
-
TipRanks Financial Blog
4/17/2026
-
Insider Monkey
4/16/2026
-
Nasdaq News: Markets
4/15/2026
-
Seeking Alpha: Transcripts
4/15/2026
-
SeekingAlpha
4/15/2026
-
Globe Newswire
4/15/2026
-
Globe Newswire
Income Statement
Total Revenue (TTM)
EBITDA (TTM)
EBIT (TTM)
Net Income (TTM)
Balance Sheet
Total Assets (Q)
Total Debt (Q)
Total Liabilities (Q)
Book Value Per Share (Q)
Cash Flow
Cash from Operations (TTM)
Cash from Investing (TTM)
Cash from Financing (TTM)
Net Change in Cash (TTM)
Filings
Filing Date
Wednesday, May 20, 2026
Period Date
Tuesday, March 31, 2026
Next Filing
Week of Aug 17 and 21 (est)
Price History
Beta
7-Day Total Return
30-Day Total Return
60-Day Total Return
90-Day Total Return
Year to Date Total Return
1-Year Total Return
2-Year Total Return
3-Year Total Return
5-Year Total Return
52-week Low
52-week High
Valuation
Enterprise Value
Price/Sales (TTM)
Price/Book (Q)
Dividends and Shares
Shares Outstanding
Dividend Per Share (Most Recent)
--
Dividend Per Share (TTM)
--
Corporate Info
Website
Phone Number
866 908 4867
Address
7921 Southpark Plaza
Littleton, CO 80120
Littleton, CO 80120
Country
Year Founded
Business Description
Sector
Industry
Vivos Therapeutics, Inc. operates as a medical technology and healthcare services company that develops and commercializes treatment modalities for patients with dentofacial abnormalities...
more